Silke Frahm

777 total citations
8 papers, 534 citations indexed

About

Silke Frahm is a scholar working on Neurology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Silke Frahm has authored 8 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 4 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Silke Frahm's work include Neurofibromatosis and Schwannoma Cases (8 papers), Neuroblastoma Research and Treatments (3 papers) and Soft tissue tumors and treatment (3 papers). Silke Frahm is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (8 papers), Neuroblastoma Research and Treatments (3 papers) and Soft tissue tumors and treatment (3 papers). Silke Frahm collaborates with scholars based in Germany, United States and France. Silke Frahm's co-authors include Eric Legius, Hilde Brems, Dominique Vidaud, P. Wolkenstein, S. Pilotti, Thomas De Raedt, Federica Perrone, Victor‐Felix Mautner, Raf Sciot and Lan Kluwe and has published in prestigious journals such as Cancer Research, Oncogene and The American Journal of Human Genetics.

In The Last Decade

Silke Frahm

8 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silke Frahm Germany 8 431 197 128 98 90 8 534
Heli Ylä‐Outinen Finland 13 372 0.9× 165 0.8× 121 0.9× 137 1.4× 82 0.9× 22 660
Tanya Basu United Kingdom 7 380 0.9× 134 0.7× 191 1.5× 113 1.2× 99 1.1× 18 686
Edwin Jousma United States 7 431 1.0× 218 1.1× 163 1.3× 58 0.6× 67 0.7× 8 611
Mary Jo Wenning United States 8 390 0.9× 131 0.7× 182 1.4× 79 0.8× 37 0.4× 9 581
Donna C. Rich United States 7 241 0.6× 88 0.4× 260 2.0× 75 0.8× 36 0.4× 8 580
Cheryl A. Moertel United States 9 171 0.4× 144 0.7× 372 2.9× 30 0.3× 52 0.6× 9 703
Paige K. Bradley United States 6 171 0.4× 54 0.3× 187 1.5× 40 0.4× 45 0.5× 8 510
Fei‐Yu Han Sweden 8 362 0.8× 63 0.3× 263 2.1× 120 1.2× 53 0.6× 11 654
Eva Pros Spain 14 133 0.3× 160 0.8× 372 2.9× 35 0.4× 116 1.3× 19 619
Caroline Louis‐Brennetot France 8 137 0.3× 171 0.9× 164 1.3× 121 1.2× 45 0.5× 10 411

Countries citing papers authored by Silke Frahm

Since Specialization
Citations

This map shows the geographic impact of Silke Frahm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Frahm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Frahm more than expected).

Fields of papers citing papers by Silke Frahm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Frahm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Frahm. The network helps show where Silke Frahm may publish in the future.

Co-authorship network of co-authors of Silke Frahm

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Frahm. A scholar is included among the top collaborators of Silke Frahm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Frahm. Silke Frahm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Farassati, Faris, Weihong Pan, Mark Piedra, et al.. (2008). Ras Signaling Influences Permissiveness of Malignant Peripheral Nerve Sheath Tumor Cells to Oncolytic Herpes. American Journal Of Pathology. 173(6). 1861–1872. 28 indexed citations
2.
Miller, Shyra J., Fatima Rangwala, Jon Williams, et al.. (2006). Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues. Cancer Research. 66(5). 2584–2591. 158 indexed citations
3.
Hirokawa, Yumiko, C. Oliver Hanemann, Armin Kurtz, et al.. (2005). Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228. Cancer Biology & Therapy. 4(4). 385–387. 30 indexed citations
4.
Mashour, George A., Silke Frahm, Faris Farassati, et al.. (2005). Differential modulation of malignant peripheral nerve sheath tumor growth by omega-3 and omega-6 fatty acids. Oncogene. 24(14). 2367–2374. 13 indexed citations
5.
Frahm, Silke, Armin Kurtz, Lan Kluwe, et al.. (2004). Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients. Cancer Cell International. 4(1). 4–4. 8 indexed citations
6.
Frahm, Silke, Victor‐F. Mautner, Hilde Brems, et al.. (2004). Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients. Neurobiology of Disease. 16(1). 85–91. 69 indexed citations
7.
Holtkamp, Nikola, David Reuß, Isis Atallah, et al.. (2004). Subclassification of Nerve Sheath Tumors by Gene Expression Profiling. Brain Pathology. 14(3). 258–264. 32 indexed citations
8.
Raedt, Thomas De, Hilde Brems, P. Wolkenstein, et al.. (2003). Elevated Risk for MPNST in NF1 Microdeletion Patients. The American Journal of Human Genetics. 72(5). 1288–1292. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026